IceCure Medical (ICCM) News Today $0.99 -0.01 (-0.87%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$0.99 0.00 (-0.02%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period IceCure Medical (NASDAQ:ICCM) Given Sell (E+) Rating at Weiss Ratings4 hours ago | marketbeat.comIceCure Medical price target raised to $2.50 from $2 at H.C. WainwrightOctober 7 at 11:30 PM | msn.comIceCure Medical (NASDAQ:ICCM) Price Target Raised to $2.50October 7 at 8:15 AM | marketbeat.comIceCure Medical Ltd - Special CallOctober 6 at 12:06 PM | seekingalpha.comIceCure Medical receives FDA marketing authorizationf or ProSense cryoablationOctober 4, 2025 | msn.comIceCure Medical Ltd. (NASDAQ:ICCM) Short Interest Down 49.8% in SeptemberOctober 4, 2025 | marketbeat.comIcecure Medical stock surges after FDA approves breast cancer treatmentOctober 3, 2025 | investing.comIceCure Medical's ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in ...October 3, 2025 | finance.yahoo.comIceCure Medical’s Treatment For Low-Risk Breast Cancer In Women Aged 70 And Over Receives FDA ApprovalOctober 3, 2025 | msn.comIceCure Medical Ltd. (NASDAQ:ICCM) Receives Average Rating of "Buy" from AnalystsOctober 3, 2025 | marketbeat.comIceCure Medical's ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive CareOctober 3, 2025 | prnewswire.comIceCure Receives FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and AboveOctober 3, 2025 | prnewswire.comIceCure Medical Showcases ProSense® Success at EUSOBI Congress 2025September 30, 2025 | msn.comIceCure's ProSense® at the European Society of Breast Imaging Congress 2025: Unlocking De-Escalation of Care in Breast Cancer, Positive Results from 5 Independent Studies PresentedSeptember 30, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) Shares Down 1.9% - What's Next?September 26, 2025 | marketbeat.comIceCure's ProSense® Featured at CIRSE 2025 Annual Meeting: Positive Clinical Results with Cryoablation from 4 Independent Studies PresentedSeptember 22, 2025 | prnewswire.comIceCure Wins Patent, Shares StuckSeptember 18, 2025 | baystreet.caIceCure Medical granted notice of allowance for U.S. patentSeptember 18, 2025 | msn.comIceCure Granted Notice of Allowance for U.S. Patent for its Next-Generation XSense™ CryoprobesSeptember 18, 2025 | prnewswire.comShort Interest in IceCure Medical Ltd. (NASDAQ:ICCM) Increases By 52.1%September 17, 2025 | marketbeat.comIceCure Receives Regulatory Approval in Israel for its Next-Generation XSense™ Cryoablation System for Breast Cancer and Other IndicationsSeptember 15, 2025 | prnewswire.comIceCure Medical announces two publications for ProSense cryoablation systemSeptember 8, 2025 | msn.comTwo New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation RateSeptember 8, 2025 | prnewswire.comIceCure Medical Ltd. (NASDAQ:ICCM) Sees Significant Decrease in Short InterestSeptember 6, 2025 | marketbeat.comIceCure Medical files $100M mixed securities shelfSeptember 4, 2025 | msn.comIceCure Medical Shareholders Approve Key Agenda Items at Special MeetingSeptember 4, 2025 | tipranks.comIceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural EfficacySeptember 4, 2025 | prnewswire.comFY2025 EPS Estimates for IceCure Medical Cut by AnalystAugust 19, 2025 | marketbeat.comIceCure Medical Ltd. (NASDAQ:ICCM) Short Interest UpdateAugust 17, 2025 | marketbeat.comFY2028 EPS Estimate for IceCure Medical Decreased by AnalystAugust 17, 2025 | marketbeat.comIceCure Medical price target lowered to $2 from $2.50 at H.C. WainwrightAugust 15, 2025 | msn.comIceCure Medical Ltd (NASDAQ:ICCM) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | insidermonkey.comIceCure Medical Reports First Half 2025 Financial ResultsAugust 14, 2025 | msn.comIceCure (ICCM) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | fool.comIceCure Reports Financial & Operational Results for the First Half of 2025August 13, 2025 | prnewswire.comExamining the Future: Icecure Medical's Earnings OutlookAugust 12, 2025 | benzinga.comIcecure Medical Ltd (ICCM) Q2 2025 Earnings Report Preview: What To Look ForAugust 12, 2025 | finance.yahoo.comWhen Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit?August 8, 2025 | finance.yahoo.comIceCure Medical (ICCM) Expected to Announce Quarterly Earnings on WednesdayAugust 8, 2025 | marketbeat.comIceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025August 6, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) Trading Down 8.9% - Should You Sell?August 5, 2025 | marketbeat.comIceCure Medical Successfully Closes Oversubscribed Rights OfferingAugust 2, 2025 | msn.comIceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 MillionJuly 29, 2025 | prnewswire.comIceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with CryoablationJuly 25, 2025 | prnewswire.comIceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription PeriodJuly 24, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) Downgraded by Wall Street Zen to "Sell"July 12, 2025 | marketbeat.comIceCure Announces Commencement of Rights OfferingJuly 10, 2025 | prnewswire.comIceCure Medical Ltd (ICCM) - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comIceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025July 3, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) shareholders have earned a 51% CAGR over the last five yearsJune 28, 2025 | finance.yahoo.com Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICCM Media Mentions By Week ICCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICCM News Sentiment▼0.340.63▲Average Medical News Sentiment ICCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICCM Articles This Week▼152▲ICCM Articles Average Week Get the Latest News and Ratings for ICCM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IceCure Medical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BWAY News OM News SKIN News SI News MGRM News TLSI News INGN News NNOX News INFU News CV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICCM) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
